ESG

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

A landmark trial reveals a new drug combination from BeOne Medicines extends life significantly in advanced stomach cancer, poised to become the new standard.

MuniNet partners with Ekinops to deploy next-gen 400G technology, promising a new era of high-speed connectivity and innovation for rural communities.

A new national scholarship from a Las Vegas physician looks beyond grades, using essays to find future doctors committed to ethical service and community care.

By blending AI innovation with a 'whole person' wellness philosophy, MERGE sets a new standard for employee experience and industry leadership.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

The free sports streamer adds 75 million households in a massive global expansion, pushing beyond the living room and into a new frontier: your car's dashboard.

The world's biggest music and AI giants partner to revolutionize music discovery and creation, promising an artist-centric approach to end generic AI content.

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.

EdgeCortix's SAKURA-II processor survives brutal radiation tests, paving the way for intelligent, real-time decision-making on satellites and the Moon.

A new 'RaiseWell Certified' label for beef just launched, promising total traceability and higher ethical standards. But will it finally clear up consumer confusion?

A promising antiviral combination for Long COVID gets a major boost, accelerating its path to a pivotal clinical trial led by top researchers.

A groundbreaking Duke trial combines a novel device to lure cancer cells with targeted immunotherapy, offering real-time tracking and new hope for patients.

An Indianapolis firm's major investment boosts domestic battery manufacturing, aiming to secure the supply chain for critical military and drone technology.

NFL's Tetairoa McMillan, MLB's Devin Williams, and NBA's Jerami Grant join Waiākea, highlighting a trend of athletes backing brands with real impact.

Array Technologies promotes two key executives, signaling an aggressive strategy to boost global revenue and product innovation in the booming solar tracker market.

At CES 2026, LIVALL unveils an AI-powered taillight and helmet ecosystem designed to eliminate blind spots and prevent collisions before they happen.

With its rare disease drug JURVIGO® in late-stage trials, Mezzion appoints a veteran leader to navigate the path to approval and commercialization.

With a major new facility planned and a dynamic market, all eyes are on Clean Harbors as it prepares to address investors at two key January events.